UNRESECTABLE
Clinical trials for UNRESECTABLE explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE trials appear
Sign up with your email to follow new studies for UNRESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental daily pill called REC-1245 in people with advanced solid tumors or lymphomas that have not responded to or are not eligible for standard therapies. The main goals are to find a safe dose and check if the drug can shrink tumors. About 170 adults wi…
Matched conditions: UNRESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Radioactive implant targets pancreatic tumors from the inside
Disease control Recruiting nowThis early study tests a new device called YntraDose™ that delivers a single dose of radiation directly into pancreatic tumors that cannot be removed by surgery. Ten participants will receive the implant along with standard chemotherapy. The main goals are to see if the procedure…
Matched conditions: UNRESECTABLE
Phase: NA • Sponsor: BetaGlue Therapeutics SpA • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New lung cancer combo aims to boost treatment completion
Disease control Recruiting nowThis study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. It combines a smaller, faster radiation field with standard chemotherapy and an immunotherapy drug called durvalumab. The goal is to see if this approach helps more p…
Matched conditions: UNRESECTABLE
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC